Clinical trial

Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and…

NCT00154713 · National Taiwan University Hospital, Other · Unknown status

Key facts

NCT number NCT00154713
Title Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment
Official title A Phase I/II Clinical Study of Immunotherapy for Advanced Colorectal Cancers Using CEA-Pulsed Dendritic Cells Mixed With Tetanus Toxoid and Subsequent IL-2 Treatment
Lead sponsor National Taiwan University Hospital, Other
Collaborators National Health Research Institutes, Taiwan
Status Unknown status
Phase Phase 1/Phase 2
Study type Interventional
Conditions Colorectal Cancer
Intervention type Biological
Interventions CEA pulsed dendritic cells
Enrollment 37
Start date Jul 1, 2005
Completion Jul 1, 2005
First posted Sep 12, 2005
Last update posted Sep 12, 2005
Countries Taiwan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies